The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease

被引:50
作者
Huang, J
DeGraves, FJ
Lenz, SD
Gao, DY
Feng, P
Li, D
Schlapp, T
Kaltenboeck, B [1 ]
机构
[1] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA
[2] Bayer AG, Anim Hlth, D-40789 Monheim, Germany
关键词
D O I
10.1073/pnas.062578399
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intracellular bacteria of the genus Chlamydia cause numerous typically chronic diseases, frequently with debilitating sequelae. Genetic determinants of disease susceptibility after infection with Chlamydia bacteria are unknown. C57BL/6 mice develop severe pneumonia and poor immunity against Chlamydia after moderate respiratory infection whereas BALB/c mice are protected from disease and develop vigorous Th1 immunity. Here we show that infected C57BL/6 macrophages release more NO synthesized by NO synthase 2 (NOS2) than BALB/c macrophages and have lower mRNA concentrations of arginase II, a competitor of NOS2 for the common substrate, L-arginine. Reduction, but not elimination, of NO production by incomplete inhibition of NOS2 abolishes susceptibility of C57BL/6 mice to Chlamydia-induced disease. Thus, the quantity of NO released by infected macrophages is the effector mechanism that regulates between pathogenic and protective responses to chlamydial infection, and genes controlling NO production determine susceptibility to chlamydial disease.
引用
收藏
页码:3914 / 3919
页数:6
相关论文
共 50 条
[1]  
Allione A, 1999, J IMMUNOL, V163, P4182
[2]   Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain [J].
Balin, BJ ;
Gerard, HC ;
Arking, EJ ;
Appelt, DM ;
Branigan, PJ ;
Abrams, JT ;
Whittum-Hudson, JA ;
Hudson, AP .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1998, 187 (01) :23-42
[3]   Arginase modulates nitric oxide production in activated macrophages [J].
Chang, CI ;
Liao, JC ;
Kuo, L .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (01) :H342-H348
[4]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[5]   Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells [J].
Dalton, DK ;
Haynes, L ;
Chu, CQ ;
Swain, SL ;
Wittmer, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :117-122
[6]   Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice [J].
Detmers, PA ;
Hernandez, M ;
Mudgett, J ;
Hassing, H ;
Burton, C ;
Mundt, S ;
Chun, S ;
Fletcher, D ;
Card, DJ ;
Lisnock, J ;
Weikel, R ;
Bergstrom, JD ;
Shevell, DE ;
Hermanowski-Vosatka, A ;
Sparrow, CP ;
Chao, YS ;
Rader, DJ ;
Wright, SD ;
Puré, E .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3430-3435
[7]   Requirement for type 2 NO synthase for IL-12 signaling in innate immunity [J].
Diefenbach, A ;
Schindler, H ;
Röllinghoff, M ;
Yokoyama, WM ;
Bogdan, C .
SCIENCE, 1999, 284 (5416) :951-955
[8]   MACROPHAGE NITRIC-OXIDE MEDIATES IMMUNOSUPPRESSION IN INFECTIOUS INFLAMMATION [J].
EISENSTEIN, TK ;
HUANG, D ;
MEISSLER, JJ ;
ALRAMADI, B .
IMMUNOBIOLOGY, 1994, 191 (4-5) :493-502
[9]   Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi [J].
Gantt, KR ;
Goldman, TL ;
McCormick, ML ;
Miller, MA ;
Jeronimo, SMB ;
Nascimento, ET ;
Britigan, BE ;
Wilson, ME .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :893-901
[10]   Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells [J].
Gotoh, T ;
Mori, M .
JOURNAL OF CELL BIOLOGY, 1999, 144 (03) :427-434